{"product_id":"9783527348701","title":"Carbohydrate-Based Therapeutics","description":"\u003cp\u003eThe book covers current progress and opens new frontiers in carbohydrate-based therapeutic applications. It presents a detailed background of the diseases coupled with the subsequent carbohydrate-based therapies. This aspect renders this book unique and will serve as a quick reference practical book of carbohydrate applications. The link between chemistry and design of novel carbohydrate-based medicines is highlighted and broad overview of all the potential applications of carbohydrates is given. Emphasis is laid on concepts used for carbohydrate drug design, structure-activity relationship and impact on health and diseases. PART I \n\u003cbr\u003eANTIMICROBIAL CARBOHYDRATE BASED THERAPIES\n\u003cbr\u003eAntibacterial Vaccines\n\u003cbr\u003eAntiviral Vaccines\n\u003cbr\u003eAntifungal Therapies\n\u003cbr\u003eAnti Influenza Therapeutics\n\u003cbr\u003eAntiadhesive Carbohydrates and Glycomimetics\n\u003cbr\u003e \n\u003cbr\u003ePART II \n\u003cbr\u003eANTI CANCER CARBOHYDRATE-BASED THERAPIES\n\u003cbr\u003e \n\u003cbr\u003eCancer Vaccines and Immunotherapy\n\u003cbr\u003eCarbohydrate Tools in Cancer Biology\n\u003cbr\u003eCarbohydrates and Glycoconjugates in Autophagy\n\u003cbr\u003eLectin Ligands to Target Cancer\n\u003cbr\u003e \n\u003cbr\u003ePART III\n\u003cbr\u003eCARBOHYDRATE-BASED THERAPIES IN METABOLIC, NEURONAL AND IMMUNE DISORDERS\n\u003cbr\u003eCarbohydrate-Based Therapeutics for Lysosomal Disorders\n\u003cbr\u003eCarbohydrate-Based Therapeutics for Neurodegenerative Diseases\n\u003cbr\u003eCarbohydrate-Based Antithrombotics\n\u003cbr\u003eGlycans and Blood Types\n\u003cbr\u003eCarbohydrate-Based Therapeutics for Autoimmune Diseases\n\u003cbr\u003eN-Glycosylation of Antibodies and Immunity\n\u003cbr\u003eType 1 Diabetes\n\u003cbr\u003e \n\u003cbr\u003ePART IV\n\u003cbr\u003eNEW FRONTIERS IN CARBOHYDRATE-BASED THERAPIES\n\u003cbr\u003eCarbohydrates for Tissue Engineering\n\u003cbr\u003eAntiangiogenic and Regenerative Medicine\n\u003cbr\u003eCarbohydrate-Based Therapeutics for Bowel Diseases\n\u003cbr\u003e Roberto Adamo joined Novartis Vaccines in 2007 where he was later appointed Head of the Carbohydrate Chemistry Laboratory, and Leader of the Conjugation \u0026amp; Synthesis Platform. After the GSK acquisition of the company he became Preclinical Representative Leader of the Conjugation Platform. He is currently Technology and Project Leader at GSK, Italy. His research focuses on the synthesis of glycans, glycoconjugates and glyconanoparticles to be used for carbohydrate-based therapeutics. He has over 70 publications in the field including a book. He is the Associate editor of the Glycoconjugate Journal.\n\u003cbr\u003e \n\u003cbr\u003eLuigi Lay is full professor at the Department of Chemistry of the University of Milan. His research interests are focused on carbohydrate chemistry and the use of synthetic glycans to investigate their biological properties. He is author of 86 publications in the field and some book chapters.\u003c\/p\u003e","brand":"Wiley-VCH","offers":[{"title":"Default Title","offer_id":48257155268843,"sku":"00000_00000_00000_00000","price":292.9,"currency_code":"SGD","in_stock":true}],"url":"https:\/\/kinokuniya.com.sg\/zh\/products\/9783527348701","provider":"Books Kinokuniya Singapore","version":"1.0","type":"link"}